At 11:00 p.m. on the evening of October 9, 2023, Cancer Cell (IF=50.3), a top-tier journal in oncology, officially launched the latest lung cancer MRD research findings of the multidisciplinary team led by Prof. Wu Yilong from the Cancer Hospital, Guangdong Provincial People’s Hospital, titled “D...

On the evening of July 24, 2023, Beijing time, Prof. Wu Yilong’s team published the research findings of Arm Group 7 (HER2-arm) of a large-scale umbrella trial (CTONG1702) and some data from a concurrent observational real-world study (CTONG 1705) in the top-tier international medical journal Nat...

Recently, a national multicenter, randomized controlled study (investigator-initiated trial, IIT) led by Prof. Chen Jiyan and Prof. Tan Ning from the Department of Cardiology of our hospital – Simplified Rapid Hydration Prevents Contrast-Associated Acute Kidney Injury Among CKD Sufferers Undergoi...

Our research team led by Wang Lijuan and Nie Kun from the Guangdong Neuroscience Institute and the Department of Neurology of our hospital made a significant breakthrough between the brain glymphatic system and the progression of Parkinson’s disease, and the research findings were published in th...

Pancreatic cancer is a highly malignant tumor in the digestive system, and is expected to become the second most lethal tumor in the next decade with its incidence rate rising year by year. Lymphatic metastasis is one of the most important metastasis pathways of pancreatic cancer. Once it occurs,...

Breast cancer has become one of the malignant tumors with the highest incidence rates worldwide. Currently, neoadjuvant chemotherapy (NAC) is the standard therapy for sufferers with locally advanced breast cancer. NAC means systemic chemotherapy performed prior to any local therapy, mainly aimed ...

Prof. Wang Lijuan’s team from the Department of Neurology of our hospital has made a significant breakthrough in the research on cognitive impairment mechanisms in α-synucleinopathies, and the research findings were published in the world-renowned journal Advanced Science (impact factor: 17.521) ...

Colorectal cancer (CRC) is a clinically common malignant tumor of the digestive tract, with its incidence and mortality rates ranking third and second among all malignant tumors, respectively, posing a serious threat to human health. Tumor metastasis is often the primary cause of patient death, a...

Distant metastasis is regarded as one of the primary causes of poor prognoses and deaths in colorectal cancer (CRC), and the liver is one of the most common organs for distant metastasis in CRC. The failure of first-line chemotherapy is recognized as one of the important causes of therapeutic dif...

Recently, Prof. Wu Yilong’s team from Guangdong Provincial People’s Hospital published an article titled “Emerging evidence and treatment paradigm of non-small cell lung cancer” in the journal of oncology Journal of Hematology & Oncology (CAS Q1, impact factor: 23.168) published by BioMed Cen...